查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370358

口蹄疫 (FMD) 疫苗市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Foot and Mouth Disease (FMD) Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2023-2028 年市场概况：

2022 年，全球口蹄疫 (FMD) 疫苗市场规模达到 19.786 亿美元。展望未来，IMARC 集团预计到 2028 年，市场规模将达到 30.707 亿美元，2023 年复合年增长率 (CAGR) 为 7.2%。2028 年。

口蹄疫 (FMD) 是由感染偶蹄类动物的跨界传染性病毒引起的。它主要影响牛，如水牛、猪、绵羊、山羊等，以及少数野生动物物种，包括鹿、野牛、骆驼、羚羊等。FMD 病毒 (FMDV) 有 7 种免疫学不同的血清型，即 O、A 、C、SAT1、SAT2、SAT3 和亚洲1. 这种病毒性疾病在动物中表现出常见症状，如嘴唇和舌头起水泡、发烧、流涎过多、厌食、肉和奶产量低等。氢氧化铝、皂苷和油製剂，用于对抗口蹄疫收缩。

口蹄疫的高流行及其对动物产品国际贸易的社会经济影响正在推动口蹄疫疫苗市场的发展。肉类加工业的发展和乳製品消费的增加也刺激了口蹄疫疫苗的需求。此外，对牲畜优质无病肉类供应的需求不断增长，进一步促进了市场成长。除此之外，有关养牛的强制性规范的实施导致大量购买疫苗来控制口蹄疫疫情。此外，全球各地的政府机构还推出了多项提高意识计划，以保护野牛和羚羊等濒危野生动物物种免受口蹄疫的侵害。全球化的不断发展以及已开发和发展中市场牲畜数量的不断增长也推动了口蹄疫疫苗市场的发展。此外，为牲畜提供安全医疗保健实践的兽医中心的不断增加也对市场成长产生了积极影响。

本报告回答的关键问题：

  • 迄今为止，全球口蹄疫（FMD）疫苗市场表现如何，未来几年将如何表现？
  • COVID-19 对全球口蹄疫 (FMD) 疫苗市场有何影响？
  • 主要区域市场有哪些？
  • 根据动物类型分類的市场是怎么样的？
  • 根据疫苗类型，市场的细分情况如何？
  • 基于配销通路的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球口蹄疫（FMD）疫苗市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球口蹄疫 (FMD) 疫苗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按动物类型分類的市场细分

  • 牛
    • 市场走向
    • 市场预测
  • 猪
    • 市场走向
    • 市场预测
  • 绵羊和山羊
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按疫苗类型分類的市场区隔

  • 常规疫苗
    • 市场走向
    • 油性疫苗
      • 市场走向
      • 市场预测
    • 氢氧化铝/皂苷类疫苗
      • 市场走向
      • 市场预测
    • 市场预测
  • 紧急疫苗
    • 市场走向
    • 市场预测

第 8 章：按配销通路分類的市场区隔

  • 政府机构
    • 市场走向
    • 市场预测
  • 经销商/药房
    • 市场走向
    • 市场预测
  • 私人兽医
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 孟加拉
      • 市场走向
      • 市场预测
    • 越南
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 阿根廷
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 奈及利亚
      • 市场走向
      • 市场预测
    • 衣索比亚
      • 市场走向
      • 市场预测
    • 伊朗
      • 市场走向
      • 市场预测
    • 阿尔及利亚
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 土耳其
      • 市场走向
      • 市场预测
    • 乔治亚州
      • 市场走向
      • 市场预测
    • 亚美尼亚
      • 市场走向
      • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特的五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Paramount Agrovet Pvt. Ltd.
    • Bayer AG
    • Biogenesis Bago
    • Boehringer Ingelheim International GmbH
    • Brilliant Bio Pharma Private Limited
    • China Animal Husbandry Group
    • FGBI "Federal Center for Animal Health"
    • Indian Immunologicals Ltd.
    • Limor de Colombia
    • Merck & Co. Inc
    • Vecol SA
    • Vetal Animal Health Products Inc.
Product Code: SR112023A2871

Abstract

Market Overview 2023-2028:

The global foot and mouth disease (FMD) vaccine market size reached US$ 1,978.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,070.7 Million by 2028, exhibiting a growth rate (CAGR) of 7.2% during 2023-2028.

The foot and mouth disease (FMD) occurs due to a transboundary, contagious virus that infects cloven-hoofed animals. It primarily affects cattle, such as buffaloes, pigs, sheep, goats, etc., and a few wildlife species, including deer, bison, camelid, antelope, etc. The FMD virus (FMDV) has seven immunologically distinct serotypes, namely O, A, C, SAT1, SAT2, SAT3, and Asia 1. This viral disease exhibits common symptoms in animals, such as blisters on lips and tongue, fever, excessive salivation, anorexia, low meat and milk productivity, etc. Several vaccines, based on aluminum hydroxide, saponin, and oil formulations, are used against FMD contraction.

The high prevalence of FMD along with its socio-economic impact on the international trade of animal products is driving the FMD vaccine market. The growing meat processing industry and the increasing consumption of dairy products are also fueling the need for FMD vaccines. Additionally, the rising demand for high-grade and disease-free meat supply from livestock is further augmenting the market growth. Apart from this, the implementation of mandatory norms regarding cattle rearing is leading to the bulk purchase of vaccines to control FMD outbreaks. Furthermore, government bodies across the globe are also introducing several awareness programs for protecting endangered wildlife species, such as bison and antelope, against FMD. Rising globalization along with the growing livestock population across both developed and developing markets is also driving the market for FMD vaccines. Furthermore, the increasing presence of veterinary centers providing safe healthcare practices for livestock is also creating a positive impact on the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global foot and mouth disease (FMD) vaccine market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on animal type, vaccine type and distribution channel.

Breakup by Animal Type:

Cattle

Pig

Sheep and Goat

Others

Breakup by Vaccine Type:

Conventional Vaccines

Oil-Based Vaccines

Aluminum hydroxide/saponin-based Vaccines

Emergency Vaccines

Breakup by Distribution Channel:

Government Organizations

Distributors/Pharmacies

Private Vet

Others

Breakup by Region:

Asia Pacific

China

India

Bangladesh

Vietnam

Korea

Others

Latin America

Brazil

Argentina

Others

Middle East and Africa

Nigeria

Ethiopia

Iran

Algeria

Others

Europe

Turkey

Georgia

Armenia

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Paramount Agrovet Pvt. Ltd., Bayer AG, Biogenesis Bago, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, China Animal Husbandry Group, FGBI "Federal Center for Animal Health", Indian Immunologicals Ltd., Limor De Colombia, Merck & Co., Inc., Vecol S.A and Vetal Animal Health Products Inc.

Key Questions Answered in This Report:

  • How has the global foot and mouth disease (FMD) vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global foot and mouth disease (FMD) vaccine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the animal type?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global foot and mouth disease (FMD) vaccine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Foot and Mouth Disease (FMD) Vaccine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Cattle
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pig
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Sheep and Goat
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Vaccine Type

  • 7.1 Conventional Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Oil-Based Vaccines
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
    • 7.1.3 Aluminum hydroxide/saponin-based Vaccines
      • 7.1.3.1 Market Trends
      • 7.1.3.2 Market Forecast
    • 7.1.4 Market Forecast
  • 7.2 Emergency Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Government Organizations
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Distributors/Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Private Vet
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Asia Pacific
    • 9.1.1 China
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 India
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Bangladesh
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Vietnam
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Korea
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Latin America
    • 9.2.1 Brazil
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Argentina
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Others
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
  • 9.3 Middle East and Africa
    • 9.3.1 Nigeria
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Ethiopia
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 Iran
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Algeria
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Others
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
  • 9.4 Europe
    • 9.4.1 Turkey
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Georgia
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Armenia
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Paramount Agrovet Pvt. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biogenesis Bago
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Brilliant Bio Pharma Private Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 China Animal Husbandry Group
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 FGBI "Federal Center for Animal Health"
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Indian Immunologicals Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Limor de Colombia
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Merck & Co. Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Vecol S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Vetal Animal Health Products Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Foot and Mouth Disease (FMD) Vaccine Market: Major Drivers and Challenges
  • Figure 2: Global: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Animal Type (in %), 2022
  • Figure 4: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Vaccine Type (in %), 2022
  • Figure 5: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 8: Global: Foot and Mouth Disease (FMD) Vaccine (Cattle) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Foot and Mouth Disease (FMD) Vaccine (Cattle) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Foot and Mouth Disease (FMD) Vaccine (Pig) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Foot and Mouth Disease (FMD) Vaccine (Pig) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Foot and Mouth Disease (FMD) Vaccine (Sheep and Goat) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Foot and Mouth Disease (FMD) Vaccine (Sheep and Goat) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Foot and Mouth Disease (FMD) Vaccine (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Foot and Mouth Disease (FMD) Vaccine (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Foot and Mouth Disease (FMD) Vaccine (Conventional Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Foot and Mouth Disease (FMD) Vaccine (Oil-Based Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Foot and Mouth Disease (FMD) Vaccine (Oil-Based Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Foot and Mouth Disease (FMD) Vaccine (Aluminum hydroxide/saponin-based Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Foot and Mouth Disease (FMD) Vaccine (Aluminum hydroxide/saponin-based Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Foot and Mouth Disease (FMD) Vaccine (Conventional Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Foot and Mouth Disease (FMD) Vaccine (Emergency Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Foot and Mouth Disease (FMD) Vaccine (Emergency Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Foot and Mouth Disease (FMD) Vaccine (Government Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Foot and Mouth Disease (FMD) Vaccine (Government Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Foot and Mouth Disease (FMD) Vaccine (Distributors/Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Foot and Mouth Disease (FMD) Vaccine (Distributors/Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Foot and Mouth Disease (FMD) Vaccine (Private Vet) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Foot and Mouth Disease (FMD) Vaccine (Private Vet) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Foot and Mouth Disease (FMD) Vaccine (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Foot and Mouth Disease (FMD) Vaccine (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: China: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: India: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: India: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Bangladesh: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Bangladesh: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Vietnam: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Vietnam: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Korea: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Korea: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Latin America: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Brazil: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Brazil: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Argentina: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Argentina: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Latin America: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Nigeria: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Nigeria: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Ethiopia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Ethiopia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Iran: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Iran: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Algeria: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Algeria: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Europe: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Turkey: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Turkey: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Georgia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Georgia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Armenia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Armenia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Europe: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Global: Foot and Mouth Disease (FMD) Vaccine Industry: SWOT Analysis
  • Figure 75: Global: Foot and Mouth Disease (FMD) Vaccine Industry: Value Chain Analysis
  • Figure 76: Global: Foot and Mouth Disease (FMD) Vaccine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Foot and Mouth Disease (FMD) Vaccine Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Animal Type (in Million US$), 2023-2028
  • Table 3: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
  • Table 4: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Foot and Mouth Disease (FMD) Vaccine Market: Competitive Structure
  • Table 7: Global: Foot and Mouth Disease (FMD) Vaccine Market: Key Players